Definium Therapeutics (DFTX) Amortizatization of Intangibles (2021 - 2026)
Definium Therapeutics (DFTX) reported Amortizatization of Intangibles of -$591000.0 for Q1 2026, up 74.07% quarter-over-quarter from -$2.3 million in Q4 2025.
Definium Therapeutics (DFTX) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 6 years of Amortizatization of Intangibles data on file, last reported at -$591000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at -$591000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$591000.0 (down 12.14% YoY), and the FY2023 annual result was $3.2 million, up 0.63% from the prior year.
- Amortizatization of Intangibles improved to -$591000.0 in Q1 2026 per DFTX's latest filing, from -$2.3 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $2.3 million in Q3 2025 and troughed at -$2.3 million in Q4 2025.
- A 5-year average of $443769.2 and a median of $800000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2025: Amortizatization of Intangibles soared 160.0% in 2022, then sank 332.45% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $780000.0 in 2022, then advanced by 2.56% to $800000.0 in 2023, then sank by 165.88% to -$527000.0 in 2024, then tumbled by 332.45% to -$2.3 million in 2025, then surged by 74.07% to -$591000.0 in 2026.
- Business Quant data shows DFTX's Amortizatization of Intangibles at -$591000.0 in Q1 2026, -$2.3 million in Q4 2025, and $2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Definium Therapeutics | 2.46 Bn | 2.09 Bn | - | -591,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -591,000.00 |
| Mar 31, 2026 | -591,000.00 |
| Dec 31, 2025 | -2.28 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Sep 30, 2025 | 2.28 Mn |
| Sep 30, 2025 | 2.28 Mn |
| Dec 31, 2024 | -527,000.00 |
| Dec 31, 2024 | -527,000.00 |
| Mar 31, 2024 | 527,000.00 |
| Mar 31, 2024 | 527,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Dec 31, 2022 | 780,000.00 |
| Dec 31, 2022 | 780,000.00 |